Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier

Journal of Virology

Volumn 75, Issue 11, 2001, Pages 5108-5118

  Sprinzl, Martin Franz ^a   Oberwinkler, Heike ^a   Schaller, Heinz ^a   Protzer, Ulrike ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Abteilung Virologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; DNA TEMPLATE; GENETIC TRANSFECTION; HEPADNAVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; VIRION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELLS, CULTURED; CYTOPLASM; DISEASE MODELS, ANIMAL; DNA, VIRAL; DUCKS; GENETIC VECTORS; GENOME, VIRAL; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; KINETICS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, PHASE-CONTRAST; RATS; SPECIES SPECIFICITY; TRANSFECTION; TUPAIA; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0035033218     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.11.5108-5118.2001     Document Type: Article

References (60)

1. Amalfitano, A. 1999. Next-generation adenoviral vectors: new and improved. Gene Ther. 6:1643-1645.
2. Birnbaum, F., and M. Nassal. 1990. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol. 64:3319-3330.
3. Boyce, F. M., and N. L. R. Bucher. 1996. Baculovirus-mediated transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93:2348-2352.
4. Bramson, J. L., F. L. Graham, and J. Gauldie. 1995. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr. Opin. Biotechnol. 6:590-595.
5. Brown, J. J., B. Parashar, H. Moshage, K. E. Tanaka, D. Engelhardt, E. Rabbani, N. Roy-Chowdhury, and J. Roy-Chowdhury. 2000. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 31:173-181.
6. Christ, M., M. Lusky, F. Stoeckel, D. Dreyer, A. Dieterle, A. I. Michou, A. Pavirani, and M. Mehtali. 1997. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol. Lett. 57:19-25.
7. Condreay, L. D., C. E. Aldrich, L. Coates, W. S. Mason, and T. T. Wu. 1990. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J. Virol. 64:3249-3258.
8. Delaney, W. E., IV, and H. C. Isom. 1998. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28:1134-1146.
9. Delaney, W. E., IV, T. G. Miller, and H. C. Isom. 1999. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-β-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob. Agents Chemother. 43:2017-2026.
10. Di, Q., J. Summers, J. B. Burch, and W. S. Mason. 1997. Major differences between WHV and HBV in the regulation of transcription. Virology 229: 25-35.
11. Eto, T., and H. Takahashi. 1999. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon. Nat. Med. 5:577-581.
12. Feitelson, A. M., L. J. DeTolla, and X. D. Zhou. 1988. A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA. J. Virol. 62:1408-1415.
13. Galle, P. R., J. Hagelstein, B. Kommerell, M. Volkmann, P. Schranz, and H. Zentgraf. 1994. In vitro experimental infection of primary human hepatocytes wilh hepatitis B virus. Gastroenterology 106:664-673.
14. Galle, P. R., H. J. Schlicht, C. Kuhn, and H. Schaller. 1989. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology 10:459-465.
15. Ganem, D. 1996. Hepadnaviridae: the viruses and their replication, p. 2703-2737. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
16. Gripon, P., C. Diot, and C. Guguen-Guillouzo. 1993. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192:534-540.
17. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589-4594.
18. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
19. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
20. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
21. Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 52:396-402.
22. Hegenbarth, S., R. Gerolami, U. Protzer, P. L. Tran, C. Brechot, G. Gerken, and P. A. Knolle. 2000. Liver sinusoidal endothelial cells are not permissive for adenovirus type 5. Hum. Gene Ther. 11:481-486.
23. Hofmann, C., V. Sandig, G. Jennings, M. Rudolph, P. Schlag, and M. Strauss. 1995. Efficient gene transfer into human hcpatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92:10099-10103.
24. Hofmann, C., and M. Strauss. 1998. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5:531-536.
25. Hoofnagle, J. H., and A. di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
26. Ilan, Y., H. Saito, N. R. Thummala,and N. R. Chowdhury. 1999. Adenovirus-mediated gene therapy of liver diseases. Semin. Liver Dis. 19:49-59.
27. Kay, A. M., D. Liu, and P. M. Hoogerbrugge. 1997. Gene therapy. Proc. Natl. Acad. Sci. USA 94:12744-12746.
28. Lau, D. T., J. Everhart, D. E. Kleiner, Y. Park, J. Vergalla, P. Schmid, and J. H. Hoofnagle. 1997. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 113:1660-1667.
29. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1998. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72:5573-5578.
30. Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. L. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
31. Liu, H. S., M. S. Jan, C. K. Chou, P. H. Chen, and N. J. Ke. 1999. Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260:712-717.
32. Loser, P., V. Sandig, I. Kirillova, and M. Strauss. 1996. Evaluation of HBV promoters for use in hepatic gene therapy. Biol. Chem. Hoppe-Seyler 377: 187-193.
33. Mabit, H., and H. Schaller. 2000. Intracellular hepadnaviral nucleocapsids are selected for secretion by envelope protein-independent membrane binding. J. Virol. 74:11472-11478.
34. Mandart, E., A. Kay, and F. Galibert. 1984. Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J. Virol. 49:782-792.
35. Nassal, M., and H. Schaller. 1996. Hepatitis B virus replication - an update. J. Viral Hepat. 3:217-226.
36. Niederau, C., T. Heintges, S. Lange, G. Goldmann, C. Niederau, L. Mohr, and D. Haussinger. 1996. Long-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B. N. Engl. J. Med. 334:1422-1427.
37. Obert, S., B. Zachmann-Brandt, E. Deindl, W. Tucker, R. Bartenschlager, and H. Schaller. 1996. A spliced hepadnaviral RNA that is essential for virus replication. EMBO J. 15:2565-2574.
38. Ohashi, K., P. L. Marion, H. Nakai, L. Meuse, J. M. Cullen, B. B. Bordier, R. Schwall, H. B. Greenberg, J. S. Glenn, and M. A. Kay. 2000. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6:327-331.
39. Pasek, M., T. Goto, W. Gilbert, B. Zink, H. Schaller, P. MacKay, G. Leadbetter, and K. Murray. 1979. Hepatitis B virus genes and their expression in E. coli. Nature 282:575-579.
40. Petersen, J., M. Dandri, S. Gupta, and C. E. Rogler. 1998. Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 95:310-315.
41. Protzer, U., M. Nassal, P. W. Chiang, M. Kirschfink, and H. Schaller. 1999. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc. Natl. Acad. Sci. USA 96:10818-10823.
42. Ragot, T., P. Opolon, and M. Perricaudet. 1997. Adenoviral gene delivery. Methods Cell Biol. 52:229-260.
43. Roggendorf, M., and T. K. Tolle. 1995. The woodchuck: an animal model for hepatitis B virus infection in man. Intervirology 38:100-112.
44. Schlicht, H. J., C. Kuhn, B. Guhr, R. J. Mattaliano, and H. Schaller. 1987. Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins. J. Virol. 61:2280-2285.
45. Schlicht, H. J., J. Salfeld, and H. Schaller. 1987. The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins hut not for virus formation. J. Virol. 61:3701-3709.
46. Schödel, F., T. Weimer, D. Fernholz, R. Schneider, R. Sprengel, G. Wildner, and H. Will. 1991. The biology of avian hepatitis B viruses, p. 53-80. In A. McLachlan (ed.), Molecular biology of the hepatitis B virus. CRC Press, Boca Raton, Fla.
47. Sells, A. M., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
48. Sprengel, R., C. Kuhn, C. Manso, and H. Will. 1984. Cloned duck hepatitis B virus DNA is infectious in Peking ducks. J. Virol. 52:932-937.
49. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
50. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824.
51. Summers, J., P. M. Smith, M. J. Huang, and M. S. Yu. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
52. Sureau, C., J. L. Romet-Lemonne, J. I. Mullins, and M. Essex. 1986. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37-47.
53. Takahashi, H., J. Fujimoto, S. Hanada, and K. J. Isselbacher. 1995. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc. Natl. Acad. Sci. USA 92:1470-1474.
54. Tuttleman, J. S., J. C. Pugh, and J. W. Summers. 1986. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol. 58:17-25.
55. Walter, E., R. Keist, B. Niederost, I. Pult, and H. E. Blum. 1996. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
56. Will, H., R. Cattaneo, G. Darai, F. Deinhardt, H. Schellekens, and H. Schaller. 1985. Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc. Natl. Acad. Sci. USA 82:891-895.
57. World Health Organization. 1996. Viral Hepatitis Prevention Board: prevention and control of hepatitis B in the community. W. H. O. Communicable Ser. 1:1-26.
58. Yan, R. Q., J. J. Su, D. R. Huang, Y. C. Gan, C. Yang, and G. H. Huang. 1996. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J. Cancer Res. Clin. Oncol. 122:283-288.
59. Zoulim, F. 1999. Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Antivir. Res. 44:1-30.
60. Zuckerman, A. J., and D. Lavanchy. 1999. Treatment options for chronic hepatitis. Antivirals look promising. BMJ 319:799-800.